Abstract
Delivery of imaging agents and pharmaceutical payloads to the central nervous system (CNS) is essential for efficient diagnosis and treatment of brain diseases. However, therapeutic delivery is often restricted by the blood-brain barrier (BBB), which prevents transport of clinical compounds to their region of interest. This review discusses the methods that have been used to avoid or overcome this barrier, presenting the use of biologically-derived nanomaterial systems as an efficient strategy for the diagnosis and treatment of CNS diseases. Biological nanomaterials have many advantages over synthetic systems, including being biodegradable, biocompatible, easily surface functionalised for conjugation of targeting moieties, and are often able to self-assemble. These abilities are discussed in relation to various systems, including liposomes, dendrimers, and viral nanoparticles.
Keywords
References
1.
Borlongan C.V.
,
Burns J.
,
Tajiri N.
2013 ) PLoS One , 8 , e78490 .
2.
Jankovic J.
(2008 ) J. Neurol. Neurosurg. Psychiatry , 79 , 368 –376 .
3.
Pardridge W.
(2006 ) Curr. Opin. Pharmacol. , 6 , 494 –500 .
4.
Faraji A.H.
, and
Wipf P.
(2009 ) Bioorg. Med. Chem. , 17 , 2950 –2962 .
5.
Molino N.M.
, and
Wang S.
(2014 ) Curr. Opin. Biotechnol. , 28 , 75 –82 .
6.
Sendelbeck S.L.
, and
Urquhart J.
(1985 ) Brain Res. , 328 , 251 –258 .
7.
Morrison P.F.
, and
Dendrick R.L.
(1986 ) J. Pharm. Sci. , 75 , 120 –128 .
8.
Remeš F.
,
Tomáš R.
,
Jindrák V.
2013 ) J. Neurosurg. , 119 , 1596 –602 .
9.
Wang L.
,
Zhang J.
,
Yu X.
2017 ) Eur. J. Hosp. Pharm. , 24 , 182 –184 .
10.
Blasberg R.G.
,
Patlak C.
, and
Fenstermacher J.D.
(1975 ) J. Pharmacol. Exp. Ther. , 195 , 73 –83 .
11.
Hersh D.S.
,
Wadajkar A.S.
,
Roberts N.
2016 ) Curr. Pharm. Des. , 22 , 1177 –1193 .
12.
Yi X.
,
Manickam D.S.
,
Brynskikh A.
2014 ) J. Control. Release , 190 , 637 –663 .
13.
Neuwelt E.A.
,
Hill S.A.
,
Frenkel E.P.
1981 ) Cancer Treat. Rep. , 65 , 39 –43 .
14.
Erdlenbruch B.
,
Schinkhof C.
,
Kugler W.
2003 ) Br. J. Pharmacol. , 139 , 685 –694 .
15.
Treat L.H.
,
McDannold N.
,
Zhang Y.
2012 ) Ultrasound Med. Biol. , 38 , 1716 –1725 .
16.
Nadal A.
,
Fuentes E.
,
Pastor J.
1995 ) Proc. Natl Acad. Sci. USA , 92 , 1426 –1430 .
17.
Pardridge W.M.
(1999 ) J. Neurovirol. , 5 , 556 –569 .
18.
Hervé F.
,
Ghinea N.
, and
Scherrmann J.
(2008 ) AAPS J. , 10 , 455 –472 .
19.
Prabhakarpandian B.
,
Shen M.-C.
,
Nichols J.B.
2013 ) Lab Chip , 13 , 1093 .
20.
Pardridge W.M.
(2005 ) NeuroRX , 2 , 3 –14 .
21.
Kageyama T.
,
Nakamura M.
,
Matsuo A.
2000 ) Brain Res. , 879 , 115 –121 .
22.
Ohtsuki S.
, and
Terasaki T.
(2007 ) Pharm. Res. , 24 , 1745 –1758 .
23.
Qin Y.
,
Fan W.
,
Chen H.
2010 ) J. Drug Target. , 18 , 536 –549 .
24.
Xie F.
,
Qin Y.
,
Zhang Q.
2012 ) Int. J. Nanomedicine , 7 , 163 –175 .
25.
Gromnicova R.
,
Davies H.A.
,
Sreekanthreddy P.
2013 ) PLoS One , 8 , e81043 .
26.
Jiang X.
,
Xin H.
,
Ren Q.
2014 ) Biomaterials , 35 , 518 –529 .
27.
Smith K.R.
, and
Borchardt R.T.
(1989 ) Pharm. Res. , 6 , 466 –473 .
28.
Lu W.
(2012 ) Curr. Pharm. Biotechnol. , 13 , 2340 –2348 .
29.
Georgieva J.
,
Hoekstra D.
, and
Zuhorn I.
(2014 ) Pharmaceutics , 6 , 557 –583 .
30.
Gao K.
, and
Jiang X.
(2006 ) Int. J. Pharm. , 310 , 213 –219 .
31.
Jones A.R.
, and
Shusta E.V.
(2007 ) Pharm. Res. , 24 , 1759 –1771 .
32.
Bickel U.
,
Yoshikawa T.
, and
Pardridge W.M.
(2001 ) Adv. Drug Deliv. Rev. , 46 , 247 –279 .
33.
Shin S.U.
,
Friden P.
,
Moran M.
1995 ) Proc. Natl Acad. Sci. USA , 92 , 2820 –2824 .
34.
Qian Z.M.
,
Li H.
,
Sun H.
2002 ) Pharmacol. Rev. , 54 , 561 –587 .
35.
Mishra V.
,
Mahor S.
,
Rawat A.
2006 ) J. Drug Target. , 14 , 45 –53 .
36.
Pardridge W.M.
(2005 ) Int. Congr. Ser. , 1277 , 49 –62 .
37.
Pardridge W.M.
,
Buciak J.L.
, and
Friden P.M.
(1991 ) J. Pharmacol. Exp. Ther. , 259 , 66 –70 .
38.
Song B.-W.
,
Vinters H.V.
,
Wu D.
2002 ) J. Pharmacol. Exp. Ther. , 301 , 605 –610 .
39.
Wu D.
,
Song B.-W.
,
Vinters H.V.
2002 ) J. Drug Target. , 10 , 239 –245 .
40.
Kurihara A.
,
Deguchi Y.
, and
Pardridge W.M.
(1999 ) Bioconjug. Chem. , 10 , 502 –511 .
41.
Lyons M.K.
,
Anderson R.E.
, and
Meyer F.B.
(1991 ) Brain Res. , 558 , 315 –320 .
42.
Lee H.W.A.J.
,
Engelhardt B.
,
Lesley J.
2000 ) J. Pharmacol. Exp. Ther. , 292 , 1048 –1052 .
43.
Shi N.
,
Zhang Y.
,
Zhu C.
2001 ) Proc. Natl Acad. Sci. USA , 98 , 12754 –12759 .
44.
Lee H.J.
,
Zhang Y.
,
Zhu C.
2002 ) J. Cereb. Blood Flow Metab. , 22 , 223 –231 .
45.
Friden P.M.
,
Walus L.R.
,
Musso G.F.
1991 ) Proc. Natl Acad. Sci. USA , 88 , 4771 –4775 .
46.
Friden P.M.
,
Olson T.S.
,
Obar R.
1996 ) J. Pharmacol. Exp. Ther. , 278 , 1491 –1498 .
47.
Pardridge W.M.
(2015 ) Expert Opin. Drug Deliv. , 12 , 207 –222 .
48.
Boado R.J.
,
Zhang Y.
,
Zhang Y.
2008 ) Biotechnol. Bioeng. , 100 , 387 –396 .
49.
Boado R.J.
, and
Pardridge W.M.
(2009 ) Drug Metab. Dispos. , 37 , 2299 –2304 .
50.
Boado R.J.
,
Hui E.K.-W.
,
Lu J.Z.
2010 ) J. Biotechnol. , 146 , 84 –91 .
51.
Demeule M.
,
Regina A.
,
Che C.
2007 ) J. Pharmacol. Exp. Ther. , 324 , 1064 –1072 .
52.
Lillis A.P.
,
Mikhailenko I.
, and
Strickland D.K.
(2005 ) J. Thromb. Haemost. , 3 , 1884 –1893 .
53.
Demeule M.
,
Currie J.-C.
,
Bertrand Y.
2008 ) J. Neurochem. , 106 , 1534 –1544 .
54.
Wagner S.
,
Zensi A.
,
Wien S.L.
2012 ) PLoS One , 7 , e32568 .
55.
Tamaru M.
,
Akita H.
,
Kajimoto K.
2014 ) Int. J. Pharm. , 465 , 77 –82 .
56.
Xin H.
,
Jiang X.
,
Gu J.
2011 ) Biomaterials , 32 , 4293 –4305 .
57.
Huang S.
,
Li J.
,
Han L.
2011 ) Biomaterials , 32 , 6832 –6838 .
58.
Xin H.
,
Sha X.
,
Jiang X.
2012 ) Biomaterials , 33 , 1673 –1681 .
59.
Xin H.
,
Sha X.
,
Jiang X.
2012 ) Biomaterials , 33 , 8167 –8176 .
60.
Ren J.
,
Shen S.
,
Wang D.
2012 ) Biomaterials , 33 , 3324 –3333 .
61.
Ke W.
,
Shao K.
,
Huang R.
2009 ) Biomaterials , 30 , 6976 –6985 .
62.
Olivier J.-C.
,
Fenart L.
,
Chauvet R.
1999 ) Pharm. Res. , 16 , 1836 –1842 .
63.
Elsabahy M.
, and
Wooley K.L.
(2012 ) Chem. Soc. Rev. , 41 , 2545 .
64.
Owens D.E.
, and
Peppas N.A.
(2006 ) Int. J. Pharm. , 307 , 93 –102 .
65.
Choyke P.L.
, and
Kobayashi H.
(2006 ) Abdom. Imaging , 31 , 224 –231 .
66.
Longmire M.
,
Choyke P.L.
, and
Kobayashi H.
(2008 ) Nanomedicine , 3 , 703 –717 .
67.
Li J.
,
Wang X.
,
Zhang T.
2014 ) Asian J. Pharm. Sci. , 10 , 81 –98 .
68.
Zhang N.
,
Wardwell P.
, and
Bader R.
(2013 ) Pharmaceutics , 5 , 329 –352 .
69.
Ahmad Z.
,
Shah A.
,
Siddiq M.
2014 ) RSC Adv. , 4 , 17028 –17038 .
70.
Nagarajan R.
(2002 ) Langmuir , 18 , 31 –38 .
71.
Thompson A.K.
,
Couchoud A.
, and
Singh H.
(2009 ) Dairy Sci. Technol. , 89 , 99 –113 .
72.
Samad A.
,
Sultana Y.
, and
Aqil M.
(2007 ) Curr. Drug Deliv. , 4 , 297 –305 .
73.
Micheli M.-R.
,
Bova R.
,
Magini A.
2012 ) Recent Pat. CNS Drug Discov. , 7 , 71 –86 .
74.
Schnyder A.
, and
Huwyler J.
(2005 ) NeuroRX , 2 , 99 –107 .
75.
Jokerst J.V.
,
Lobovkina T.
,
Zare R.N.
2011 ) Nanomedicine , 6 , 715 –728 .
76.
Rose J.S.
,
Neal J.M.
, and
Kopacz D.J.
(2005 ) Reg. Anesth. Pain Med. , 30 , 275 –285 .
77.
Du D.
,
Chang N.
,
Sun S.
2014 ) J. Control. Release , 182 , 99 –110 .
78.
Lai F.
,
Fadda A.M.
, and
Sinico C.
(2013 ) Expert Opin. Drug Deliv. , 10 , 1003 –1022 .
79.
Ko Y.T.
,
Bhattacharya R.
, and
Bickel U.
(2009 ) J. Control. Release , 133 , 230 –237 .
80.
Qin J.
,
Zhang R.-X.
,
Li J.-L.
2014 ) Eur. J. Pharm. Sci. , 58 , 63 –71 .
81.
Zhang Y.
,
Zhu C.
, and
Pardridge W.M.
(2002 ) Mol. Ther. , 6 , 67 –72 .
82.
Huwyler J.
,
Wu D.
, and
Pardridge W.M.
(1996 ) Proc. Natl Acad. Sci. USA , 93 , 14164 –14169 .
83.
Pardridge W.M.
(2003 ) Methods Enzymol. , 373 , 507 –528 .
84.
Sebestik J.
,
Niederhafner P.
, and
Jezek J.
(2011 ) Amino Acids , 40 , 301 –370 .
85.
Hong S.
,
Bielinska A.U.
,
Mecke A.
2004 ) Bioconjug. Chem. , 15 , 774 –782 .
86.
Satija J.
,
Gupta U.
, and
Jain N.K.
(2007 ) Crit. Rev. Ther. Drug Carrier Syst. , 24 , 257 –306 .
87.
Janaszewska A.
,
Ziemba B.
,
Ciepluch K.
2012 ) New J. Chem. , 36 , 350 –353 .
88.
Klementieva O.
,
Aso E.
,
Filippini D.
2013 ) Biomacromolecules , 14 , 3570 –3580 .
89.
Janaszewska A.
,
Klajnert-Maculewicz B.
,
Marcinkowska M.
2017 ) Nano Res. , 11 , 1204 –1226 .
90.
Mccarthy J.M.
,
Appelhans D.
, and
Rogers M.S.
(2013 ) Prion , 7 , 198 –202 .
91.
Supattapone S.
,
Nguyen H.-O.
B.,
Cohen F.E.
1999 ) Proc. Natl Acad. Sci. USA , 96 , 14529 –14534 .
92.
Svenson S.
, and
Tomalia D.A.
(2012 ) Adv. Drug Deliv. Rev. , 64 , 102 –115 .
93.
Engelberth S.A.
,
Hempel N.
, and
Bergkvist M.
(2015 ) Bioconjug. Chem. , 26 , 1766 –1774 .
94.
Ouyang L.
,
Pan J.
,
Zhang Y.
2009 ) Synth. Commun. , 39 , 4039 –4052 .
95.
Wu D.
, and
Pardridge W.M.
(1999 ) Proc. Natl Acad. Sci. USA , 96 , 254 –259 .
96.
Bickel U.
,
Yoshikawa T.
,
Landaw E.M.
1993 ) Proc. Natl Acad. Sci. USA , 90 , 2618 –2622 .
97.
Rousselle C.
,
Clair P.
,
Smirnova M.
2003 ) J. Pharmacol. Exp. Ther. , 306 , 371 –376 .
98.
Liu H.
,
Zhang W.
,
Ma L.
2014 ) Int. J. Pharm. , 476 , 1 –8 .
99.
Yu Y.J.
, and
Watts R.J.
(2013 ) Neurotherapeutics , 10 , 459 –472 .
100.
Régina A.
,
Demeule M.
,
Ché C.
2009 ) Br. J. Pharmacol. , 155 , 185 –197 .
101.Angiochem Inc. (2017 ) A phase II, open-label, multi-center study of ANG1005 in patients with recurrent high-grade glioma. https://clinicaltrials.gov [accessed 10 December 2017].
102.
Loh J.W.E.N.
,
Schneider J.
,
Carter M.
2010 ) J. Pharm. Sci. , 99 , 4326 –4337 .
103.
Aljebory A.M.
, and
Alsalman T.M.
(2017 ) Imp. J. Interdiscip. Res. , 3 , 233 –242 .
104.
Park J.H.
,
Saravanakumar G.
,
Kim K.
2010 ) Adv. Drug Deliv. Rev. , 62 , 28 –41 .
105.
Trapani A.
,
De Giglio E.
,
Cafagna D.
2011 ) Int. J. Pharm. , 419 , 296 –307 .
106.
Aktaş Y.
,
Yemisci M.
,
Andrieux K.
2005 ) Bioconjug. Chem. , 16 , 1503 –1511 .
107.
Gu J.
,
Al-Bayati K.
, and
Ho E.A.
(2017 ) Drug Deliv. Transl. Res. , 7 , 497 –506 .
108.
Yildiz I.
,
Shukla S.
, and
Steinmetz N.F.
(2011 ) Curr. Opin. Biotechnol. , 22 , 901 –908 .
109.
Yildiz I.
,
Lee K.L.
,
Chen K.
2013 ) J. Control. Release , 172 , 568 –578 .
110.
Cohen B.A.
,
Kaloyeros A.E.
, and
Bergkvist M.
(2012 ) J. Porphyr. Phthalocyanines , 16 , 47 –54 .
111.
Douglas T.
, and
Young M.
(1998 ) Nature , 393 , 152 –155 .
112.
Loo L.
,
Guenther R.H.
,
Lommel S.A.
2008 ) Chem. Commun. , 0, 88 –90 .
113.
Narayanan K.B.
, and
Han S.S.
(2017 ) Adv. Colloid Interface Sci. , 248 , 1 –19 .
114.
Strauss J.H.
, and
Sinsheimer R.L.
(1963 ) J. Mol. Biol. , 7 , 43 –54 .
115.
Kovacs E.W.
,
Hooker J.M.
,
Romanini D.W.
2007 ) Bioconjug. Chem. , 18 , 1140 –1147 .
116.
Toropova K.
,
Basnak G.
,
Twarock R.
2008 ) J. Mol. Biol. , 375 , 824 –836 .
117.
Stephanopoulos N.
,
Tong G.J.
,
Hsiao S.C.
2010 ) ACS Nano , 4 , 6014 –6020 .
118.
Cohen B.A.
, and
Bergkvist M.
(2013 ) J. Photochem. Photobiol. B Biol. , 121 , 67 –74 .
119.
Galaway F.A.
, and
Stockley P.G.
(2013 ) Mol. Pharm. , 10 , 59 –68 .
120.
ElSohly A.M.
,
Netirojjanakul C.
,
Aanei I.L.
2015 ) Bioconjug. Chem. , 26 , 1590 –1596 .
121.
Valegård K.
,
Liljas L.
,
Fridborg K.
1990 ) Nature , 345 , 36 –41 .
122.
Ashley C.E.
,
Carnes E.C.
,
Phillips G.K.
2011 ) ACS Nano , 5 , 5729 –5745 .
123.
Curley S.M.
,
Castracane J.
,
Bergkvist M.
2018 ) MRS Advances , 1 –6 . https://doi.org/10.1557/adv.2018.357.